ABL1 and acute lymphoblastic leukemia: Interestingly, BCR-ABL + primary ALL cells were more resistant against ABT-199 than BCR-ABL-negative leukemic blasts with MFI-reduction to 71.3% and 39.0%, respectively (p = 0.04).